wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38733768-CC2FADAE-F459-475A-BB5C-1362E7C4A398
Q38733768-CC2FADAE-F459-475A-BB5C-1362E7C4A398
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38733768-CC2FADAE-F459-475A-BB5C-1362E7C4A398
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies.
P2860
Q38733768-CC2FADAE-F459-475A-BB5C-1362E7C4A398
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38733768-CC2FADAE-F459-475A-BB5C-1362E7C4A398
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bf009b5dea8e99330e53ad406010d3033319bf77
P2860
A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease